[{"orgOrder":0,"company":"Sunnybrook Health Sciences Centre","sponsor":"US Department of Defense | Walter Reed National Military Medical Center","pharmaFlowCategory":"DU","therapeuticArea":"Trauma (Emergency, Injury, Surgery)","country":"","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Oxandrolone","moa":"Androgen Receptor","graph1":"Trauma (Emergency, Injury, Surgery)","graph2":"Phase III","graph3":"Sunnybrook Health Sciences Centre","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Trauma","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Sunnybrook Health Sciences Centre \/ US Department of Defense | Walter Reed National Military Medical Center","highestDevelopmentStatusID":"10","companyTruncated":"Sunnybrook Health Sciences Centre \/ US Department of Defense | Walter Reed National Military Medical Center"},{"orgOrder":0,"company":"Science Valley Research Institute","sponsor":"Stin Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"","productType":"Other Small Molecule","year":"2025","type":"Inapplicable","leadProduct":"Oxandrolone","moa":"Androgen Receptor","graph1":"Undisclosed","graph2":"Phase II","graph3":"Science Valley Research Institute","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Implant","sponsorNew":"Science Valley Research Institute \/ Stin Pharma","highestDevelopmentStatusID":"8","companyTruncated":"Science Valley Research Institute \/ Stin Pharma"}]

Find Clinical Drug Pipeline Developments & Deals for CS-2944

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Science Valley Research Institute

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Science Valley Research Institute

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Oxandrolone is a Other Small Molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of unspecified medical condition.

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          May 16, 2025

                          Lead Product(s) : Oxandrolone

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase II

                          Sponsor : Stin Pharma

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Sunnybrook Health Sciences Centre

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Sunnybrook Health Sciences Centre

                          Country arrow
                          ChemOutsourcing
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 26, 2022

                          Lead Product(s) : Oxandrolone

                          Therapeutic Area : Trauma (Emergency, Injury, Surgery)

                          Highest Development Status : Phase III

                          Sponsor : US Department of Defense | Walter Reed National Military Medical Center

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank